FDA Adverse Event
Injury
Summary report: N
FLEXTEND II
MDR report key: 1951485
·
Received January 6, 2011
Report
- Report Number
- 2124215-2010-23051
- Event Type
- Injury
- Date Received
- January 6, 2011
- Date of Event
- June 1, 2010
- Report Date
- November 26, 2010
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- PMA / PMN Number
- NOTAPVD
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE PATIENT WAS HOSPITALIZED AND TREATED FOR THE EFFUSION. THIS LEAD STILL REMAINS IMPLANTED AND IN SERVICE. NO ADDITIONAL INFORMATION IS AVAILABLE. IF ANY ADDITIONAL INFORMATION DOES BECOME AVAILABLE, THIS REPORT WILL BE UPDATED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE RIGHT VENTRICULAR (RV) LEAD EXPERIENCED SHORTNESS OF BREATH AND A PLEURAL EFFUSION. IT IS UNKNOWN IF THE EFFUSION WAS A RESULT OF THE IMPLANTATION PROCESS. NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | FLEXTEND II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4097 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Life Threatening| R |